MedTrace Logo

Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban

NCT05841147 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-05-03

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate whether intravenous injection of tilofiban can reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization.The main questions it aims to answer are:

* Is it safe to inject tirofiban intravenously during interventional treatment of intracranial aneurysms？
* What dose of tirofiban is safe and effective?

Conditions

  • Intracranial Aneurysm

Interventions

DRUG

Tirofiban

Intravenous administration of tirofiban

DRUG

normal saline

Intravenous administration of normal saline

Sponsors & Collaborators

  • Lu Hua

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-25
Primary Completion
2023-07-31
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05841147 on ClinicalTrials.gov